1 | 2W8G |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
(3-ENDO,8-ANTI)-8-BENZYL-3-(10,11-DIHYDRO-5H-DIBENZO[A,D][7]ANNULEN-5-YLOXY)-8-AZONIABICYCLO[3.2.1]OCTANE |
BS2 |
|
0.7 |
SHOW |
2 | 2X00 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
GYMNODIMINE A |
GYN |
|
0.65 |
SHOW |
3 | 3SH1 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
METHYLLYCACONITINE |
MLK |
|
0.6 |
SHOW |
4 | 3SIO |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
METHYLLYCACONITINE |
MLK |
|
0.57 |
SHOW |
5 | 1UW6 |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
(S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE |
NCT |
|
0.51 |
SHOW |
6 | 5O8T |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
STRYCHNINE |
SY9 |
|
0.51 |
SHOW |
7 | 4DBM |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
(3-exo)-8,8-dimethyl-3-(4-{[(1-methyl-2-oxo-1,2-dihydroquinolin-4-yl)oxy]methyl}-1H-1,2,3-triazol-1-yl)-8-azoniabicyclo[3.2.1]octane |
0J0 |
|
0.51 |
SHOW |
8 | 1UV6 |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
2-[(AMINOCARBONYL)OXY]-N,N,N-TRIMETHYLETHANAMINIUM |
CCE |
|
0.51 |
SHOW |
9 | 5BP0 |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
5-fluoronicotine |
FN1 |
|
0.51 |
SHOW |
10 | 3ZDH |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
(2R)-N,N-dimethyl-4-(1-methylimidazol-2-yl)oxy-butan-2-amine |
XRS |
|
0.5 |
SHOW |
11 | 3ZDG |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
3-(dimethylamino)butyl dimethylcarbamate |
XRX |
|
0.49 |
SHOW |
12 | 5KE4 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
2-((5-(3,7-Diazabicyclo[3.3.1]nonan-3-yl)pyridin-3-yl)oxy)-N,N-dimethylethanamine |
6S7 |
|
0.48 |
SHOW |
13 | 4WV9 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
(3-exo)-8,8-dimethyl-3-[4-(pyridin-4-yl)-1H-1,2,3-triazol-1-yl]-8-azoniabicyclo[3.2.1]octane |
MD4 |
|
0.47 |
SHOW |
14 | 4ZRU |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
3-[(2S)-pyrrolidin-2-ylethynyl]pyridine |
TI9 |
|
0.47 |
SHOW |
15 | 5BRX |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
(2R,3S,5R,7S)-2-(pyridin-3-yl)-1-azatricyclo[3.3.1.1~3,7~]decane |
TI4 |
|
0.47 |
SHOW |
16 | 5Y2Q |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
3-[[4-[(3,4-dichlorophenyl)methyl]piperidin-4-yl]methoxy]pyridine |
8L3 |
|
0.47 |
SHOW |
17 | 4AFT |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
VARENICLINE |
QMR |
|
0.47 |
SHOW |
18 | 3U8L |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
1-(5-phenylpyridin-3-yl)-1,4-diazepane |
09Q |
|
0.46 |
SHOW |
19 | 4UM3 |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
1-(6-bromopyridin-3-yl)-1,4-diazepane |
09R |
|
0.45 |
SHOW |
20 | 3WTN |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
(2Z)-1-[(6-chloropyridin-3-yl)methyl]imidazolidin-2-imine |
N2Y |
|
0.45 |
SHOW |
21 | 2BYQ |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
EPIBATIDINE |
EPJ |
|
0.45 |
SHOW |
22 | 5SYO |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
(1R,5S)-1,2,3,4,5,6-HEXAHYDRO-8H-1,5-METHANOPYRIDO[1,2-A][1,5]DIAZOCIN-8-ONE |
C5E |
|
0.45 |
SHOW |
23 | 4BQT |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
(1R,5S)-1,2,3,4,5,6-HEXAHYDRO-8H-1,5-METHANOPYRIDO[1,2-A][1,5]DIAZOCIN-8-ONE |
C5E |
|
0.45 |
SHOW |
24 | 2YME |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
1-methyl-N-[(1R,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide |
CWB |
|
0.45 |
SHOW |
25 | 6NP0 |
5-hydroxytryptamine receptor 3A | Mus musculus |
P23979 (5HT3A_MOUSE) |
1-methyl-N-[(1R,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide |
CWB |
|
0.44 |
SHOW |
26 | 4AFH |
Achbp | Capitella teleta |
I6L8L2 (I6L8L2_CAPTE) |
Alpha-Lobeline |
L0B |
|
0.44 |
SHOW |
27 | 4ZK4 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
(5R)-1-methyl-7-[5-(propan-2-yloxy)pyridin-3-yl]-1,7-diazaspiro[4.4]nonane |
TII |
|
0.43 |
SHOW |
28 | 2YMD |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
SEROTONIN |
SRO |
|
0.41 |
SHOW |
29 | 2Y57 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
[(1R,5S)-8-PHENETHYL-8-AZABICYCLO[3.2.1]OCTAN-3-YL] BENZOATE |
V37 |
|
0.41 |
SHOW |
30 | 4UM1 |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
1-(5-ethoxypyridin-3-yl)-1,4-diazepane |
09P |
|
0.41 |
SHOW |
31 | 5AFN |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
Alpha-Lobeline |
L0B |
|
0.41 |
SHOW |
32 | 6UR8 |
Neuronal acetylcholine receptor subunit alpha-4 | Homo sapiens |
P43681 (ACHA4_HUMAN) |
VARENICLINE |
QMR |
|
0.41 |
SHOW |